See more : Holcim Ltd (HCMLY) Income Statement Analysis – Financial Results
Complete financial analysis of Sunset Island Group, Inc. (SIGO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sunset Island Group, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Red Metal Resources Ltd. (RMES.CN) Income Statement Analysis – Financial Results
- Al Khalij Commercial Bank (al khaliji) P.Q.S.C. (KCBK.QA) Income Statement Analysis – Financial Results
- Medexus Pharmaceuticals Inc. (MEDXF) Income Statement Analysis – Financial Results
- Wisdom Sports Group (1661.HK) Income Statement Analysis – Financial Results
- Calidi Biotherapeutics, Inc. (CLDI) Income Statement Analysis – Financial Results
Sunset Island Group, Inc. (SIGO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.sunsetislandgroup.com
About Sunset Island Group, Inc.
Sunset Island Group, Inc., through its subsidiary, VBF Brands, engages in the cultivation of medical cannabis in California, the United States. It also offers consulting and services to clients that operate in the medical marijuana business. Sunset Island Group, Inc. was incorporated in 2005 and is based in San Clemente, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 2.90M | 1.46M | 250.34K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 588.30K | 288.33K | 0.00 | 27.18K | 446.88 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 2.31M | 1.17M | 250.34K | -27.18K | -446.88 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 79.73% | 80.27% | 100.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 690.69K | 120.36 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.91K |
| SG&A | 0.00 | 0.00 | 1.32M | 1.14M | 594.70K | 1.40M | 690.69K | 10.03K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 1.32M | 1.14M | 594.70K | 1.40M | 690.69K | 10.03K |
| Cost & Expenses | 0.00 | 0.00 | 1.91M | 1.43M | 697.65K | 1.42M | 690.69K | 10.03K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 428.69K | 799.28K | 1.26M | 1.32M | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 102.94K | 27.18K | 690.69 | 120.36 |
| EBITDA | 0.00 | 0.00 | -1.01M | 290.40K | -344.37K | -1.97M | -690.69K | -9.91K |
| EBITDA Ratio | 0.00% | 0.00% | 34.31% | 2.03% | -137.56% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | 996.00K | 29.67K | -447.31K | -1.42M | -690.69K | -10.03K |
| Operating Income Ratio | 0.00% | 0.00% | 34.31% | 2.03% | -178.68% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | -2.43M | -538.54K | -3.07M | -1.89M | 0.00 | 0.00 |
| Income Before Tax | 0.00 | 0.00 | -1.44M | -508.88K | -3.52M | -3.32M | -690.69K | -10.03K |
| Income Before Tax Ratio | 0.00% | 0.00% | -49.50% | -34.82% | -1,406.27% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | -236.56K | -1.00 | -4.00 | 2.00 | -688.69 | -120.36 |
| Net Income | 0.00 | 0.00 | -1.44M | -508.88K | -3.52M | -3.32M | -690.69K | -10.03K |
| Net Income Ratio | 0.00% | 0.00% | -49.50% | -34.82% | -1,406.27% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | -0.24 | -0.09 | -0.65 | -0.62 | -0.02 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.24 | -0.09 | -0.65 | -0.62 | -0.02 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 5.92M | 5.80M | 5.39M | 5.38M | 42.37M | 50.03M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 5.92M | 5.80M | 5.39M | 5.38M | 42.37M | 50.03M |
Source: https://incomestatements.info
Category: Stock Reports